TherapeuticsMD (TXMD) Operating Leases (2019 - 2025)
Historic Operating Leases for TherapeuticsMD (TXMD) over the last 7 years, with Q3 2025 value amounting to $5.4 million.
- TherapeuticsMD's Operating Leases fell 633.55% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year decrease of 633.55%. This contributed to the annual value of $5.5 million for FY2024, which is 3076.83% down from last year.
- According to the latest figures from Q3 2025, TherapeuticsMD's Operating Leases is $5.4 million, which was down 633.55% from $5.7 million recorded in Q2 2025.
- Over the past 5 years, TherapeuticsMD's Operating Leases peaked at $8.5 million during Q1 2021, and registered a low of $5.4 million during Q3 2025.
- Moreover, its 5-year median value for Operating Leases was $7.4 million (2022), whereas its average is $7.1 million.
- In the last 5 years, TherapeuticsMD's Operating Leases surged by 863.08% in 2023 and then plummeted by 3076.83% in 2024.
- TherapeuticsMD's Operating Leases (Quarter) stood at $8.1 million in 2021, then decreased by 8.61% to $7.4 million in 2022, then rose by 8.63% to $8.0 million in 2023, then tumbled by 30.77% to $5.5 million in 2024, then dropped by 2.36% to $5.4 million in 2025.
- Its Operating Leases stands at $5.4 million for Q3 2025, versus $5.7 million for Q2 2025 and $6.0 million for Q1 2025.